时间：2025-12-23 12:23:19 来源：网络整理编辑：時尚
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a
The Food and Drug Administration has approved the first pill embedded with a sensor that can alert a patient’s physician or caregiver when it’s been ingested, the agency announced on Monday.
The Japanese drug maker Otsuka Pharmaceutical won the approval for an upgraded version of Abilify, the antipsychotic drug first approved 15 years ago to treat schizophrenia, bipolar disorder, and depression. Otsuka collaborated with Proteus Digital Health, the Silicon Valley company that designed the futuristic sensor technology.
SEE ALSO:Big Pharma’s big push to get patients to take their medsThe new product, which will be sold as Abilify MyCite, can be swallowed just like any other pill. When that happens, the ingestible sensor inside it sends a message to a patch worn by the patient, which then transmits the information to a mobile app that the patient can monitor. If a patient opts to allow it, the patient’s caregivers and doctor can access the data online, too.
The FDA’s decision Monday comes a year and a half after the agency rejected the product. At the time, the agency said it needed more information about how the product is used and how human error could create risks. Monday’s hard-won approval could come as a big boost for Otsuka, which had lost market share after Abilify went generic but will now have a way to make the product stand out.
Forgetfulness and cloudy thinking can be symptoms of the mental health conditions that Abilify is approved to treat, and patients with mental illness are known to struggle to take medication consistently. But the new product will also be labeled with a caveat: There’s no evidence that the technology can help patients take their medication as prescribed.
The landmark approval is the latest in an expansive rethinking of what constitutes a treatment. In September, the FDA approved the first mobile app to treat certain substance use disorders, developed by the Boston company Pear Therapeutics.
TopicsHealth
Mom discovers security cameras hacked, kids' bedroom livestreamed2025-12-23 12:17
Katy Perry talks 'Rise,' her next batch of songs, and how to survive Twitter2025-12-23 12:12
Metallica to seek and destroy your eardrums with new album this fall2025-12-23 11:46
WhatsApp announces plans to share user data with Facebook2025-12-23 11:23
Donald Trump's tangled web of Russian influence2025-12-23 11:18
This German startup wants to be your bank (without being a bank)2025-12-23 11:06
Fiji wins first2025-12-23 11:03
Balloon fanatic Tim Kaine is also, of course, very good at harmonica2025-12-23 10:56
Nate Parker is finally thinking about the woman who accused him of rape2025-12-23 10:00
Teacher absolutely nails it with new homework policy2025-12-23 09:55
New Zealand designer's photo series celebrates the elegance of aging2025-12-23 12:17
More than half of women in advertising have faced sexual harassment, report says2025-12-23 12:03
These glasses hide a fitness tracker on your face2025-12-23 12:02
There's a big piece of fake chicken stuck to this phone case2025-12-23 11:50
Tesla's rumored P100D could make Ludicrous mode even more Ludicrous2025-12-23 11:46
We asked linguists if Donald Trump speaks like that on purpose2025-12-23 11:33
Fiji wins first2025-12-23 11:04
Pole vaulter claims his penis is not to blame2025-12-23 11:00
You can now play 'Solitaire' and 'Tic2025-12-23 10:46
Give your kitchen sponge a rest on this adorable bed2025-12-23 09:59
